Ivermectin for malaria control in mass drug administration programmes - Authors' reply
- PMID: 35338869
- DOI: 10.1016/S1473-3099(22)00156-6
Ivermectin for malaria control in mass drug administration programmes - Authors' reply
Conflict of interest statement
We declare no competing interests.
Comment in
-
Ivermectin for malaria control in mass drug administration programmes.Lancet Infect Dis. 2022 Apr;22(4):449-450. doi: 10.1016/S1473-3099(22)00152-9. Lancet Infect Dis. 2022. PMID: 35338868 No abstract available.
Comment on
-
Mass drug administration of ivermectin and dihydroartemisinin-piperaquine against malaria in settings with high coverage of standard control interventions: a cluster-randomised controlled trial in The Gambia.Lancet Infect Dis. 2022 Apr;22(4):519-528. doi: 10.1016/S1473-3099(21)00557-0. Epub 2021 Dec 15. Lancet Infect Dis. 2022. PMID: 34919831
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
